SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-003465
Filing Date
2020-02-05
Accepted
2020-02-05 16:11:49
Documents
59
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q arwr-10q_20191231.htm   iXBRL 10-Q 1494380
2 EX-31.1 arwr-ex311_10.htm EX-31.1 10487
3 EX-31.2 arwr-ex312_8.htm EX-31.2 10930
4 EX-32.1 arwr-ex321_9.htm EX-32.1 6316
5 EX-32.2 arwr-ex322_7.htm EX-32.2 6563
  Complete submission text file 0001564590-20-003465.txt   5500368

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA arwr-20191231.xsd EX-101.SCH 41108
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arwr-20191231_cal.xml EX-101.CAL 48446
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arwr-20191231_def.xml EX-101.DEF 135727
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE arwr-20191231_lab.xml EX-101.LAB 364888
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arwr-20191231_pre.xml EX-101.PRE 279952
55 EXTRACTED XBRL INSTANCE DOCUMENT arwr-10q_20191231_htm.xml XML 838594
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38042 | Film No.: 20578864
SIC: 2834 Pharmaceutical Preparations